Want to see BLSM full AI Analyst Report?

BlossomHill Therapeutics, Inc. (BLSM) Ownership - Who Owns BlossomHill Therapeutics, Inc.?

Q: What percentage of BlossomHill Therapeutics, Inc. (BLSM) stock is held by retail investors?

According to the latest TipRanks data, approximately 41.50% of BlossomHill Therapeutics, Inc. (BLSM) stock is held by retail investors.

Q: Who owns the most shares of BlossomHill Therapeutics, Inc. (BLSM)?

Jean Cui Jingrong owns the most shares of BlossomHill Therapeutics, Inc. (BLSM).

Q: What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

16 Followers

BlossomHill Therapeutics, Inc. (BLSM) Ownership Overview

55.71% Insiders

1.42% Mutual Funds

1.37% ETFs

41.50% Public Companies and

Individual Investors

The ownership structure of BlossomHill Therapeutics, Inc. (BLSM) stock is a mix of institutional, retail, and individual investors. , 55.71% is owned by Insiders, and 41.50% is owned by Public Companies and Individual Investors.

The ownership structure of BlossomHill Therapeutics, Inc. (BLSM) stock is a mix of institutional, retail, and individual investors. Approximately 2.79% of the company’s stock is owned by Institutional Investors, 55.71% is owned by Insiders, and 41.50% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Aug 12, 2026	Orbimed Advisors Llc	xxxxxxxxxxxxx	$10000000
Aug 12, 2026	Carl Gordon	xxxxxxxxxxxxx	$10000000
Aug 10, 2026	Bihua Chen	xxxxxxxxxxxxx	$5000000
Aug 10, 2026	John Schmid	xxxxxxxxxxxxx	$96000

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
3,973,138	Insider	12.50%	54,630,648
3,973,138	Insider	12.50%	54,630,648
3,614,034	Insider	11.37%	49,692,968
2,714,279	Insider	8.54%	37,321,336
2,714,279	Insider	8.54%	37,321,336
578,524	Insider	1.82%	7,954,705
435,554	Institution	1.37%	5,988,868
347,400	Institution	1.09%	4,776,750
134,099	Insider	0.42%	1,843,861
73,691	Institution	0.23%	1,013,251

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
347,400	Institution	1.09%	4,776,750
73,691	Institution	0.23%	1,013,251
19,632	Institution	0.06%	269,940
10,932	Institution	0.03%	150,315

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard	316,217	Institution	0.99%	5,894,285
Vanguard	108,405	Institution	0.34%	2,020,669
Vanguard	9,495	Institution	0.03%	176,987
Vanguard	951	Institution	<0.01%	17,727
Vanguard	350	Institution	<0.01%	6,524
Vanguard	136	Institution	<0.01%	2,535

FAQ

Who Owns BlossomHill Therapeutics, Inc. (BLSM)?

Currently, no data Available

What percentage of BlossomHill Therapeutics, Inc. (BLSM) stock is held by institutional investors?

Currently, no data Available

What percentage of BlossomHill Therapeutics, Inc. (BLSM) stock is held by retail investors?

According to the latest TipRanks data, approximately 41.50% of BlossomHill Therapeutics, Inc. (BLSM) stock is held by retail investors.

Who owns the most shares of BlossomHill Therapeutics, Inc. (BLSM)?

Jean Cui Jingrong owns the most shares of BlossomHill Therapeutics, Inc. (BLSM).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.